8-K - Intensity Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Intensity Therapeutics, Inc. received a letter from Nasdaq on March 5, 2026, confirming it has regained compliance with Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement after maintaining a $1.00 per share closing bid price for 10 consecutive business days from February 19 to March 4, 2026. The matter is now closed, following prior noncompliance notices in June 2025 and December 2025.

Key Takeaways

1Received Nasdaq compliance letter on March 5, 2026

2Regained compliance with Minimum Bid Price Requirement under Rule 5550(a)(2)

3Maintained $1.00 closing bid price for 10 business days: February 19–March 4, 2026

4Initial noncompliance notice: June 6, 2025 (180 days to December 3, 2025)

5Second notice: December 4, 2025 (additional 180 days to June 1, 2026)

6Issued press release on March 6, 2026 (Exhibit 99.1)

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued March 6 , 202 6 104 Cover Page Interactive Data F

Other Event

Exhibits (2)

8-K

99.1

EX-99.1